The DOI matches its Crossref record.
Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF- alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.
Abstract
C57BL/6 mice infected with the ME-49 strain of Toxoplasma gondii develop a progressive encephalitis culminating in 100% mortality between 12 and 15 wk after intraperitoneal inoculation of the parasite. Moreover, when injected at 4 wk after infection with anti-IFN-gamma mAb, progression of toxoplasmic encephalitis is markedly accelerated, resulting in death of the animals by 9 to 12 days posttreatment. In this study, we investigated the expression of mRNAs encoding cytokines as well as lymphocyte and macrophage markers during the development of toxoplasmic encephalitis. High levels of lymphocyte CD4 and CD8 surface Ag transcript were detected in the brains of mice throughout the infection. In addition from 2 to 4 wk we found elevations of Th1 (IFN-gamma and IL-2) but not of Th2 (IL-4 and IL-5) cytokine mRNAs. The elevation in Th1 cytokines was accompanied by increases in the expression of monokine (IL-1, IL-6, IL-10, granulocyte macrophage-colony stimulating factor [GM-CSF], and TNF-alpha) mRNAs, as well as markers expressed by activated macrophages (major histocompatibility class II [Ia], inducible nitric oxide synthase [iNOS] and macrophage activation gene 1 [Mag-1]). Interestingly, after 8 wk of infection with T. gondii we observed a dramatic decrease of Th1 cytokine and most monokine (IL-1, IL-6, GM-CSF, and TNF-alpha) as well as Mag-1 and iNOS mRNA levels. This down-regulation was associated with enhanced necrosis and neutrophilic infiltrates in the brain accompanied by increased expression of genes expressed specifically by the tachyzoite stage of T. gondii (T. gondii surface antigen 1 [SAG-1] and T. gondii surface antigen 2 [SAG-2]). Similarly, in mice chronically infected with T. gondii and treated with anti-IFN-gamma mAb the resulting pathology was associated with decreased expression of TNF-alpha and iNOS and increased expression of SAG-1 and SAG-2. Moreover, treatment with anti-TNF-alpha mAb also resulted in enhanced pathology, which correlated with low levels of iNOS mRNA and high levels of tachyzoite-specific mRNAs. Together these results suggest that reactivation of T. gondii results from a down-regulation of IFN-gamma and TNF-alpha expression leading to decreased macrophage or microglial cell activation, release of parasite growth, and subsequent tissue damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection
Denkers, E. Y., & Gazzinelli, R. T. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.569 · Cited by 701
Self-citationLytic Cycle of Toxoplasma gondii
Black, M. W., & Boothroyd, J. C. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.3.607-623.2000 · Cited by 554
Transforming growth factor beta: the good, the bad, and the ugly.
Wahl, S. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1587 · Cited by 486
Scharton-Kersten, T. M., Yap, G., Magram, J., & Sher, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1261 · Cited by 433
Self-citationAcute Toxoplasmosis Leads to Lethal Overproduction of Th1 Cytokines
Mordue, D. G., Monroy, F., La Regina, M., Dinarello, C. A., & Sibley, L. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4574 · Cited by 396
Role of nitric oxide in parasitic infections
James, S. L. (1995) · Microbiological Reviews · doi:10.1128/mmbr.59.4.533-547.1995 · Cited by 364
Immune response and immunopathology during toxoplasmosis
Dupont, C. D., Christian, D. A., & Hunter, C. A. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0339-3 · Cited by 359
NO Inhibitions: Antimicrobial Properties of Nitric Oxide
De Groote, M. A., & Fang, F. C. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.supplement_2.s162 · Cited by 358
Toxoplasma Effectors Targeting Host Signaling and Transcription
Hakimi, M.-A., Olias, P., & Sibley, L. D. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00005-17 · Cited by 339
Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.
Stenger, S., Donhauser, N., Thüring, H., Röllinghoff, M., & Bogdan, C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1501 · Cited by 331
OBERMEIER, F., KOJOUHAROFF, G., HANS, W., SCHÖLMERICH, J., GROSS, V, & FALK, W. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00878.x · Cited by 317
Carrera, L., Gazzinelli, R. T., Badolato, R., Hieny, S., Muller, W., Kuhn, R., & Sacks, D. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.515 · Cited by 315
Self-citationBohne, W., Heesemann, J., & Gross, U. (1994) · Infection and Immunity · doi:10.1128/iai.62.5.1761-1767.1994 · Cited by 306
Antimicrobial mechanisms of fish phagocytes and their role in host defense
Neumann, N. F., Stafford, J. L., Barreda, D., Ainsworth, A. J., & Belosevic, M. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00037-4 · Cited by 303
Stenger, S., Thüring, H., Röllinghoff, M., & Bogdan, C. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.783 · Cited by 302
Activation of TLR2 and TLR4 by Glycosylphosphatidylinositols Derived from Toxoplasma gondii
Debierre-Grockiego, F., Campos, M. A., Azzouz, N., Schmidt, J., Bieker, U., Resende, M. G., Mansur, D. S., Weingart, R., Schmidt, R. R., Golenbock, D. T., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1129 · Cited by 301
Self-citationPhysiological and pathophysiological roles of nitric oxide in the central nervous system
Szabó, C. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(96)00159-1 · Cited by 297
Wynn, T. A., Eltoum, I., Oswald, I. P., Cheever, A. W., & Sher, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1551 · Cited by 266
Self-citationScharton-Kersten, T., Contursi, C., Masumi, A., Sher, A., & Ozato, K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1523 · Cited by 217
Self-citationHost immune responses to Toxoplasma gondii
Sasai, M., Pradipta, A., & Yamamoto, M. (2018) · International Immunology · doi:10.1093/intimm/dxy004 · Cited by 202
Interleukin‐10 modulates susceptibility in experimental cerebral malaria
KOSSODO, S., MONSO, C., JUILLARD, P., VELU, T., GOLDMAN, M., & GRAU, G. E. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00290.x · Cited by 180
Giese, N. A., Gabriele, L., Doherty, T. M., Klinman, D. M., Tadesse-Heath, L., Contursi, C., Epstein, S. L., & Morse, H. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1535 · Cited by 160
Interleukin-18 (IL-18) Enhances Innate IL-12-Mediated Resistance to Toxoplasma gondii
Cai, G., Kastelein, R., & Hunter, C. A. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6932-6938.2000 · Cited by 116
Deckert, M., Sedgwick, J. D., Fischer, E., & Schlüter, D. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0062-z · Cited by 82
The role of macrophages in protective and pathological responses to Toxoplasma gondii
Park, J., & Hunter, C. A. (2020) · Parasite Immunology · doi:10.1111/pim.12712 · Cited by 54
Metadata
- Authors
- Gazzinelli, R. T., Eltoum, I., Wynn, T. A., & Sher, A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1993-10-01
- Volume
- 151
- Issue
- 7
- Pages
- 3672-3681
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1553735692
- Cited by
- 349
- References
- 0
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.